Build status - In Progress

Observational Characterization of the Treatment Course of Patients With Thyroid Eye Disease

Observational Characterization of the Treatment Course of Patients With Thyroid Eye Disease
Recruiting
18 years - 99 years
All
Phase N/A
1 Location

Brief description of study

This study will: • Evaluate standard-of-care (SOC) treatment for TED in a real-world setting • Evaluate effectiveness of the treatment in terms of protrusion of the eyeball (proptosis) • Show if the SOC treatment has any effect on eye anatomy and function and fi the appearance of the subject’s eyes will change • Evaluate the tolerability of SOC in subjects with TED • Look at the subjects’ medical and disease history and certain characteristics like demographics (e.g. age, sex, weight, race, and ethnicity) and if they have an effect on treatment outcome

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Thyroid eye disease (TED)
  • Age: 18 years - 99 years
  • Gender: All

Male or Female 18 years of age or older Thyroid Eye Disease

Updated on 04 Aug 2024. Study ID: 849119

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center